Population health, meal by meal.
Omada brings virtual care to millions through employers and payers. SNAQ brings RCT-backed nutrition AI to the meal level. Different layers of the same stack.
In short.
Omada Health is a public B2B-distributed virtual care company (NASDAQ: OMDA) for prediabetes, T2D, hypertension and MSK, recently launched 'Meal Map' with the OmadaSpark AI agent. SNAQ is an AI nutritionist with photo carb counting validated at 5.5 g mean absolute error, a personal glucose model, and an RCT in eClinicalMedicine. The two are more complementary than competitive: Omada owns employer distribution; SNAQ provides the meal-level intelligence underneath.
At a glance.
- Omada is employer- or payer-funded, with 1M+ cumulative participants and 29+ peer-reviewed publications on behavioural and clinical outcomes.
- Omada's Meal Map (2025) introduced nutrient-quality coloring with the OmadaSpark AI agent. SNAQ photo carb counting is validated at 5.5 g mean absolute error in a peer-reviewed study.
- SNAQ has a 2025 RCT specifically on Time-in-Range improvement (+6.6 pp) in T1D on AID. Omada's evidence centres on behavioural and weight outcomes.
- Omada is US-only. SNAQ is global.
- Omada is direct-to-employer; SNAQ is direct-to-consumer with a provider-facing option (SNAQ Care).
Feature by feature.
Structured comparison based on publicly available information, last reviewed May 2026.
| Feature | SNAQ | Omada Health |
|---|---|---|
| Access model | Direct-to-consumer + provider (SNAQ Care) | Employer / payer / health-plan funded |
| Photo meal logging accuracy | ✅ Validated at 5.5 g mean absolute carb error | ⚠ Meal Map nutrient categorisation, accuracy not peer-reviewed |
| Glucose prediction | ✅ | ❌ |
| Cohort coverage | T1D, T2D, prediabetes, GLP-1 | Prediabetes, T2D, hypertension, MSK, GLP-1 |
| Peer-reviewed clinical evidence (product-specific) | ✅ RCT 2025, eClinicalMedicine (TIR) | ✅ 29+ studies on behavioural / weight outcomes |
| Geographic availability | Global | US only |
| Cost to member | From $2.66/mo (3-year plan), 7-day free trial | Free via employer / health plan |
| Best for | Meal-level intelligence for diabetes and GLP-1 users | Population-scale virtual care funded by employers / payers |
Sources: Herzig D. et al., JMIR mHealth and uHealth, 2020 (carb counting accuracy) Piazza et al., eClinicalMedicine 2025 (RCT NCT05671679, Time-in-Range) SNAQ research overview Omada Health Meal Map launch, GlobeNewswire, October 2025 Omada Health product and outcomes pages
Why users switch.
If your employer doesn't offer Omada
Most US employees don't have Omada access today. SNAQ is available directly, no eligibility gate.
Meal-level intelligence
Omada's strength is behavioural curriculum and human coaching at population scale. SNAQ's strength is what to do at this meal, right now.
RCT evidence across cohorts
Omada's evidence base is largely behavioural and outcomes-based across prediabetes, T2D and adjacent conditions. SNAQ's published RCT (eClinicalMedicine 2025) measured Time-in-Range in T1D adults on automated insulin delivery, demonstrating nutrition-support outcomes a behavioural-curriculum program is not designed to capture.
Honest take.
Choose SNAQ if…
- Your employer doesn't offer Omada, or you're outside the US.
- You have T1D, T2D, prediabetes or take a GLP-1, and want a meal-AI tool.
- You want meal-level intelligence in addition to (or instead of) a structured curriculum.
Consider Omada Health if…
- Your employer or health plan funds Omada and you want a structured cohort program.
- You want a longer-form curriculum and human coaching as the primary intervention.
Bottom line
Omada is the gold standard for employer-funded virtual care. SNAQ is the meal-AI layer most virtual care programs lack. Often complements rather than competes.
Published randomised controlled trial evidence, measured against standard care in T1D patients on automated insulin delivery systems.
Source: eClinicalMedicine (The Lancet), 2025 · Piazza et al. · NCT05671679